UvA-DARE ( Digital Academic Repository ) X-linked cardioskeletal myopathy and neutropenia ( Barth syndrome ) : respiratory-chain abnormalities in cultured fibroblasts

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic linkage studies.

  2005cited by this paper
• Altered kinetics of cytochrome c oxidase in a patient with severe mitochondrial encephalomyopathy.

  1995cited by this paper
• Barth syndrome: clinical observations and genetic linkage studies.

  1994cited by this paper
• Multiple syndromes of 3-methylglutaconic aciduria.

  1993cited by this paper
• Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28.

  1993cited by this paper
• Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria.

  1991cited by this paper
• Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28.

  1991cited by this paper
• X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria.

  1991cited by this paper
• An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

  1983cited by this paper

• Dodecanedioic Acid: Alternative Carbon Substrate or Toxic Metabolite?

  2025cites this paper
• Barth Syndrome: TAFAZZIN Gene, Cardiologic Aspects, and Mitochondrial Studies—A Comprehensive Narrative Review

  2025cites this paper
• Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts.

  2024cites this paper
• Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae

  2023cites this paper
• Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism

  2023cites this paper
• Modeling congenital heart disease: lessons from mice, hPSC-based models, and organoids

  2022cites this paper
• Defects in lipid homeostasis reflect the function of TANGO2 in Acyl-CoA metabolism

  2022cites this paper
• NAD supplementation improves mitochondrial performance of cardiolipin mutants.

  2022cites this paper
• Longitudinal Observational Study of Cardiac Outcome Risk Factor Prediction in Children, Adolescents, and Adults with Barth Syndrome

  2022cites this paper
• Plasmalogens and Chronic Inflammatory Diseases

  2021cites this paper
• Splicing mutation in TAZ gene leading to exon skipping and Barth syndrome.

  2021cites this paper
• Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid

  2021cites this paper
• Interplay between cardiolipin and plasmalogens in Barth syndrome

  2021cites this paper
• Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria

  2020cites this paper
• Fetal hydrops – a review and a clinical approach to identifying the cause

  2020cites this paper
• Role of Tafazzin in Mitochondrial Function, Development and Disease

  2020cites this paper
• TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

  2020cites this paper
• Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

  2020cites this paper
• Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins

  2020cites this paper
• Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria

  2020cites this paper
• Mitochondrial Communication in Physiology, Disease and Aging

  2019cites this paper
• AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome

  2019cites this paper
• Mitochondrial dysfunctions in barth syndrome

  2019cites this paper
• Barth syndrome: mechanisms and management

  2019cites this paper
• TACG_A_171481 95..106

  2019cites this paper
• A Critical Appraisal of the Tafazzin Knockdown Mouse Model of Barth Syndrome: What Have We Learned About Pathogenesis and Potential Treatments?

  2019cites this paper
• Mitochondrial dysfunction and its role in tissue-specific cellular stress

  2018cites this paper
• The role of nonbilayer phospholipids in mitochondrial structure and function

  2018cites this paper
• Cardiac mitochondrial structure and function in tafazzin-knockdown mice.

  2018cites this paper
• Development of Enzyme Replacement Therapy in Mammalian Models of Barth Syndrome

  2017cites this paper
• Barth Syndrome with Late-Onset Cardiomyopathy: A Missed Opportunity for Diagnosis.

  2017cites this paper
• Barth syndrome cardiomyopathy

  2017influential citation
• Utilisation du modèle levure pour la recherche de voies thérapeutiques contre le syndrome de Barth

  2017cites this paper
• Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy

  2017cites this paper
• Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome

  2017cites this paper
• Letters to the EditorReply

  2017cites this paper
• Role of Cardiolipin in Mitochondrial Signaling Pathways

  2017cites this paper
• Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies

  2016influential citation
• Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease

  2016cites this paper
• Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes

  2015cites this paper
• Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndrome[S]

  2015cites this paper
• Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies

  2015cites this paper
• DMM020438 509..526

  2015cites this paper
• Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome

  2015cites this paper
• Haematological abnormalities in mitochondrial disorders.

  2015cites this paper
• A biochemical and cell biological characterization of TAFAZZIN in a novel Barth syndrome cell model

  2015cites this paper
• Mis-sesnse mutations in Tafazzin (TAZ) that escort to mild clinical symptoms of Barth syndrome is owed to the minimal inhibitory effect of the mutations on the enzyme function: In-silico evidence

  2014cites this paper
• Cardiolipin remodeling in diabetic heart.

  2014cites this paper
• Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions.

  2013cites this paper
• The Sum of the Parts

  2013cites this paper
• Seven functional classes of Barth syndrome mutation.

  2013cites this paper
• Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome.

  2013influential citation
• Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome[S]

  2013cites this paper
• Novel mutations in the TAZ gene in patients with Barth syndrome.

  2013cites this paper
• Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts.

  2013cites this paper
• The power of yeast to model diseases of the powerhouse of the cell.

  2013cites this paper
• Supramolecular organisation of the mitochondrial respiratory chain: a new challenge for the mechanism and control of oxidative phosphorylation.

  2012cites this paper
• Cardiolipin and Mitochondrial Phosphatidylethanolamine Have Overlapping Functions in Mitochondrial Fusion in Saccharomyces cerevisiae*

  2012cites this paper
• Myocardial Regulation of Lipidomic Flux by Cardiolipin Synthase

  2012cites this paper
• Identification of cellular functions of cardiolipin as physiological modifiers of barth syndrome

  2012cites this paper
• Cardiolipin and Mitochondrial Phosphatidylethanolamine Have Overlapping Functions in Mitochondrial Fusion in

  2012cites this paper
• Therapy with Recombinant Leukocyte Growth Factors

  2012cites this paper
• Characterization of a Transgenic Short Hairpin RNA-Induced Murine Model of Tafazzin Deficiency

  2011cites this paper
• New developments on the functions of coenzyme Q in mitochondria.

  2011cites this paper
• Barth syndrome mutations that cause tafazzin complex lability

  2011cites this paper
• Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies

  2011cites this paper
• Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth

  2010cites this paper
• Die Rolle des Proteins Fcj1 und der Untereinheiten Su e/Su g der F1FO-ATP-Synthase bei der Entstehung von Cristae und Crista Junctions in Mitochondrien

  2010cites this paper
• Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.

  2009cites this paper
• Cardiolipin metabolism in Barth syndrome

  2009cites this paper
• Neutropenia and Primary Immunodeficiency Diseases

  2009cites this paper
• Structural and functional organization of the mitochondrial respiratory chain: a dynamic super-assembly.

  2009cites this paper
• Correction for The Cardiolipin Transacylase, Tafazzin, Associates with Two Distinct Respiratory Components Providing Insight into Barth Syndrome

  2008cites this paper
• Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata

  2008cites this paper
• Chapter 3 – The Role of Recombinant Leukocyte Colony-Stimulating Factors in the Neonatal Intensive Care Unit

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) A mass spectrometric approach to investigate cardiolipin metabolism in Barth syndrome

  2007cites this paper
• New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome.

  2007cites this paper
• UvA-DARE ( Digital Academic Repository ) A mass spectrometric approach to investigate cardiolipin metabolism in Barth syndrome

  2007cites this paper
• Role of cardiolipin alterations in mitochondrial dysfunction and disease.

  2007cites this paper
• Up-regulation of the Cell Integrity Pathway in Saccharomyces cerevisiae Suppresses Temperature Sensitivity of the pgs1Δ Mutant*

  2007cites this paper
• Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients.

  2006cites this paper
• Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome.

  2005cites this paper
• Loss of function of KRE5 suppresses temperature sensitivity of mutants lacking mitochondrial anionic lipids.

  2004cites this paper
• The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome.

  2004cites this paper
• Congenital neutropenia: advances in diagnosis and treatment

  2004cites this paper
• Absence of Cardiolipin Results in Temperature Sensitivity, Respiratory Defects, and Mitochondrial DNA Instability Independent of pet56*

  2004cites this paper
• Genetics of inherited cardiomyopathies

  2004cites this paper
• X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update

  2004cites this paper
• Neutropenia in the Neonatal Intensive Care Unit

  2004cites this paper
• Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome

  2003cites this paper
• X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060)

  1999cites this paper
• Jcb: Article

  year unknowncites this paper